IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.802
AS - Asia 7.266
EU - Europa 6.743
SA - Sud America 1.417
AF - Africa 136
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 15
Totale 29.403
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.612
CN - Cina 2.749
SG - Singapore 2.305
UA - Ucraina 1.797
BR - Brasile 1.226
PL - Polonia 955
IT - Italia 868
DE - Germania 844
HK - Hong Kong 804
FI - Finlandia 508
GB - Regno Unito 446
FR - Francia 426
VN - Vietnam 383
IN - India 329
TR - Turchia 307
IE - Irlanda 293
RU - Federazione Russa 287
CA - Canada 105
BD - Bangladesh 82
SE - Svezia 71
AR - Argentina 66
CZ - Repubblica Ceca 54
MX - Messico 54
BE - Belgio 51
IQ - Iraq 48
ZA - Sudafrica 47
ID - Indonesia 42
EC - Ecuador 37
IR - Iran 36
KR - Corea 27
JP - Giappone 26
ES - Italia 25
AT - Austria 23
NL - Olanda 21
AU - Australia 20
CH - Svizzera 19
KE - Kenya 19
PK - Pakistan 18
VE - Venezuela 18
EG - Egitto 17
UZ - Uzbekistan 16
EU - Europa 15
MA - Marocco 15
CL - Cile 14
CO - Colombia 14
MU - Mauritius 14
PY - Paraguay 14
SA - Arabia Saudita 14
JO - Giordania 10
PE - Perù 10
UY - Uruguay 10
IL - Israele 9
KZ - Kazakistan 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
BO - Bolivia 6
ET - Etiopia 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
DZ - Algeria 5
GR - Grecia 5
NP - Nepal 5
RO - Romania 5
AL - Albania 4
CR - Costa Rica 4
JM - Giamaica 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
PT - Portogallo 3
BB - Barbados 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TJ - Tagikistan 2
TO - Tonga 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
Totale 29.385
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.486
Jacksonville 1.290
Singapore 1.093
Ashburn 995
Warsaw 950
Houston 914
Hong Kong 801
Ann Arbor 790
Cambridge 681
Seattle 581
Chandler 579
Wilmington 572
Princeton 527
Beijing 517
Nanjing 466
Brescia 307
New York 298
Dublin 291
Dearborn 279
Istanbul 238
Los Angeles 225
Helsinki 221
Nanchang 182
Shenyang 148
Munich 141
The Dalles 137
Des Moines 131
Hebei 131
Ho Chi Minh City 126
Moscow 116
Buffalo 110
Tianjin 105
Milan 100
Jinan 98
Changsha 92
Shanghai 88
São Paulo 88
San Diego 77
Hanoi 74
Pune 73
San Francisco 70
Jiaxing 69
Dallas 65
Lancaster 65
Redondo Beach 61
Toronto 60
London 52
Kunming 51
Chicago 48
San Mateo 48
Turku 47
Brussels 45
Hangzhou 45
Santa Clara 44
Dong Ket 42
Verona 42
Ningbo 40
Brno 38
Rio de Janeiro 38
Kocaeli 36
Augusta 35
Guangzhou 35
Ardabil 32
Leawood 32
Zhengzhou 32
San Donà Di Piave 31
Brooklyn 28
Haikou 28
Brasília 27
Monmouth Junction 27
Taizhou 27
Denver 26
Boardman 25
Johannesburg 25
Norwalk 24
Tokyo 24
Romola 23
Montreal 22
Lanzhou 21
Poplar 21
Belo Horizonte 20
Phoenix 20
Mexico City 19
Orem 18
Frankfurt am Main 17
Jakarta 17
Nairobi 17
Ankara 16
Atlanta 16
Rome 16
Changchun 15
Da Nang 15
Mumbai 15
Orange 15
Taiyuan 15
Baghdad 14
Basel 14
Boston 14
Dhaka 14
Totale 19.545
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 293
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 288
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 279
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 248
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 247
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 234
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 224
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 222
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 210
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 205
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 203
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 192
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 190
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 183
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 177
The D3 dopamine receptor: From structural interactions to function. 171
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 169
Palbociclib inhibits proliferation of human adrenocortical tumor cells 168
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 165
Age-related changes of enkephalin in rat spinal cord 163
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 163
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 162
A new pharmacological approach to the facilitation of acetylcholine transmission. 159
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 158
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 155
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 155
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 154
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 152
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 151
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 151
A superfusion method for the study of calcium fluxes from pituitary cells. 150
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 149
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 149
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 147
Synapsin III alterations in Parkinson's disease 147
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 146
ALPHA-SYNUCLEIN MODULATES SYNAPSIN III IN NIGROSTRIATAL DOPAMINERGIC NEURONS: IMPLICATIONS FOR PARKINSON'S DISEASE 145
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 145
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 145
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 144
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 143
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 139
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 137
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 137
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 137
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 136
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 136
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 135
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 135
Pharmacological basis for dopamine D-2 receptor diversity 134
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 133
Ormoni Anteroipofisari 132
Dopamine receptors are present in rat and human esophagus 132
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 131
Caveolins in rhabdomyosarcoma 131
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 131
Nerve growth factor, D2 receptor isoforms, and pituitary tumors 131
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 129
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 128
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 128
Nerve growth factor signaling in prostate health and disease. 128
Sex-related variations in serum nerve growth factor concentration in humans. 127
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 127
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 126
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 126
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 126
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 126
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 125
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 125
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 124
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 124
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 124
Different neurotransmitter systems are involved in the development of esophageal achalasia 123
The NMDA/D1 receptor complex as a new target in drug development 123
Vasoactive Intestinal Polypeptide (VIP) selectively stimulates prolactin release in healthy women 123
Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens 123
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 122
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 122
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 121
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 121
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 121
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 120
Nerve growth factor in pituitary development and pituitary tumors 120
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 120
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 119
Presenilin-2 mutations alter cystatin C trafficking in mouse primary neurons. 119
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 119
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 119
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 119
Synapsin III Alteration in Parkinson's disease 119
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 119
PGRN gene silencing in primary neuronal cultures: a model of FTLD-U 119
Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine 119
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter 118
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 118
Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus 117
[Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. 117
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 117
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 116
Afferent fibers mediate the increse of met-enkephalin elicited in rat spinal cord by localized pain. 116
Totale 14.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.745
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.577 0 0 0 0 0 411 193 465 565 287 536 120
2021/20222.156 195 455 54 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.763 110 32 142 132 93 372 60 53 387 30 44 308
2024/20254.242 23 46 58 545 471 346 407 105 511 286 877 567
2025/20264.733 753 1.112 658 1.335 755 120 0 0 0 0 0 0
Totale 30.224